Infectious or Allergic Chronic Laryngitis Follow-up
- Author: Stefano Berliti, MD, FACP; Chief Editor: Arlen D Meyers, MD, MBA more...
Further Inpatient Care
- Hospital admission is necessary when signs and symptoms of toxemia exist and intravenous antibiotic therapy is needed (eg, severe bacterial or fungal infections).
- ICU monitoring may be required when stridor or any other symptom suggesting important involvement of the airways exists. This may occur in the late stages of diseases, such as Wegener granulomatosis, rheumatoid arthritis, relapsing polychondritis, or amyloidosis, or with conditions that severely compromise the structure and functions of the larynx. Airway monitoring becomes of paramount importance.
- When a risk of aspiration exists, alternative forms of feeding may be used until the risk subsides.
- When contagious diseases are suspected, the appropriate isolation procedures must be implemented before identification of the responsible organisms and initiation of the indicated medical treatment.
- Further inpatient care is required for all cases in which verification of the response to the therapy and its optimization prior to discharge are needed.
- If chronic laryngitis is part of a systemic disease, then the treatment plan must take into account the different necessities that vary from case to case.
Further Outpatient Care
- Further outpatient care is indicated whenever adherence to therapy may not be optimal and verification is believed to be necessary.
- Further outpatient care is indicated when prophylactic and epidemiological recommendations must be reinforced (eg, abstinence from cigarette smoking, airborne isolation and medical treatments for household contacts of a patient with tuberculosis).
- Further outpatient care is indicated when the physician wants to ensure that the pathologic findings of the larynx are regressing according to treatment plan expectations.
Transfer
Transfer may be problematic only when respiration is compromised and risk of acute insufficiency exists. In these circumstances, preventive measures must be undertaken, and appropriate surgical instrumentation to perform a tracheostomy should be available.
Complications
- The most difficult problems that occur in patients with chronic laryngitis are as follows:
- Systemic spread or spread to the surrounding structures of the eventual infectious process
- Laryngeal stenosis due to acute suprainfection of a chronic situation and consequent edema or stenosis secondary to a long-term process that has not been addressed
- Vocal cords with excessive reactive growth and permanent damage to their structure and, consequently, to their function
- Transformation into cancer
Prognosis
- Prognosis mainly relates to the causative process.
Patient Education
- Detailed information regarding occupational/environmental substances and/or habits that might have caused a patient's chronic laryngitis must be provided. Strategies to avoid the causative factors and their consequences must be taught.
- Avoidance of cigarette smoking and secondhand smoke are of paramount importance.
- A speech therapist must be consulted when voice rehabilitation is needed. Recommend appropriate use of the voice.
- Educate patients regarding appropriate handling of medications. Inhaled corticosteroids may cause chronic laryngitis, presumably because of the local immunosuppressive effect, thus causing oral candidiasis. Inhaled corticosteroids can cause dysphonia, probably secondary to a myopathic effect. These effects can be minimized through dose reduction, switching to twice-daily administration, mouth rinsing, and the use of a spacer device.
- Patients should be aware that obesity is a risk factor for the development of GERD, probably related to increased intra-abdominal pressure.
- For excellent patient education resources, visit eMedicine's Ear, Nose, and Throat Center. Also, see eMedicine's patient education article Laryngitis.
Ahmed TF, Khandwala F, Abelson TI, Hicks DM, Richter JE, Milstein C, et al. Chronic laryngitis associated with gastroesophageal reflux: prospective assessment of differences in practice patterns between gastroenterologists and ENT physicians. Am J Gastroenterol. Mar 2006;101(3):470-8. [Medline].
Fuchs M, Bücheler M. [Chronic hyperplastic laryngitis following treatment of hypertension with angiotensin converting enzyme-inhibitor]. HNO. Nov 2004;52(11):998-1000. [Medline].
Kania RE, Hartl DM, Badoual C, Le Maignan C, Brasnu DF. Primary mucosa-associated lymphoid tissue (MALT) lymphoma of the larynx. Head Neck. Mar 2005;27(3):258-62. [Medline].
Akhavan A, Ajalloueyan M, Ghanei M, Moharamzad Y. Late laryngeal findings in sulfur mustard poisoning. Clin. Toxicol (Phila). Feb. 2009;47(2):142-4. [Medline].
Hiraga A, Kamitsukasa I, Araki N, Yamamoto H. Hoarseness in pellagra. J Clin Neurosci. Jun 2011;18(6):870-1. [Medline].
Oz F, Kalekoglu N, Karakullukçu B, Oztürk O, Oz B. Lipoid proteinosis of the larynx. J Laryngol Otol. Sep 2002;116(9):736-9. [Medline].
Vaezi MF, Richter JE, Stasney CR, et al. Treatment of chronic posterior laryngitis with esomeprazole. Laryngoscope. February 2006;116 (2):254-60. [Medline].
Bluestone, Stool, Kenna. Pediatric Otolaryngology. Vol 2. Philadelphia:. WB Saunders Co;1996:1144-52, 1253-9.
Cummings CW. Otolaryngology Head and Neck Surgery. 3rd ed. St. Louis:. Mosby-Year Book;1998:1985-1992.
Ebenfelt A, Finizia C. Absence of bacterial infection in the mucosal secretion in chronic laryngitis. Laryngoscope. Nov 2000;110(11):1954-6. [Medline].
Fu YS, Wenig BM, Abemayor E, Wenig BL. Head and Neck Pathology. Philadelphia:. Churchill Livingstone;2001:319-323.
Hanson DG, Jiang JJ. Diagnosis and management of chronic laryngitis associated with reflux. Am J Med. Mar 6 2000;108 Suppl 4a:112S-119S. [Medline].
Lee KJ. Essential Otolaryngology-Head and Neck Surgery. 7th ed. Appleton & Lange;1998:830-838.
Paparella MM. Otolaryngology. 3rd ed. Philadelphia:. WB Saunders Co;1991:2247-2253.

